| Name | Title | Contact Details |
|---|---|---|
Candis Fields-Johnson |
Head of Information Technology | Profile |
Bobby Narasimham Rao |
Chief Information Security Officer (CISO) | Profile |
Jeff Haskill |
Vice President, Cyber Security and Infrastructure Services | Profile |
Kemberton is a leading provider of technology-enabled revenue cycle management services to hospitals for complex claims. We specialize in the management and collection of workers compensation, motor vehicle accident claims, veteran administration and the resolution of insurance denials for hospitals and physician practice groups. Kemberton helps accelerate collection times and maximize reimbursements for over 300 hospital clients across 35 states, resulting in over $1.5 billion dollars of incremental cash payments for our clients.
Kinetik Medical Devices Inc is a Agoura Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Tomah Health, we are inspiring health, wellness and balance for patients, families and our community, together in care. We have been caring for our community since 1952 and Tomah Health advances excellence in care by providing quality, compassionate healthcare close to home. We are growing for you and our community to continue to provide superior healthcare for generations to come.
Q² Solutions, a Quintiles Quest joint venture Launched in 2015, Q² Solutions (pronounced Q-squared) is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q² Solutions is a quality driven, responsive partner with strong global experience and deep scientific and medical expertise. The Q² Solutions joint venture was formed by Quintiles and Quest Diagnostics, combining the best of each parent organizations clinical trials laboratory services capabilities.
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.